Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA), occurring in up to 40% of individuals during the course of their disease. Early diagnosis is critical, particularly given the shared clinico-epidemiological features between advanced RA-ILD and idiopathic pulmonary fibrosis (IPF). We therefore sought to define the molecular basis of this overlap through comparative profiling of serum proteins in RA-ILD and IPF. Multiplex ELISA was used to profile 45 protein biomarkers encompassing cytokines/chemokines, growth factors, and matrix metalloproteinases in sera derived from RA patients with/without ILD, individuals with IPF, and healthy controls. Levels of selected serum proteins were compared between patient subgroups using adjusted linear regression, Principal Component Analysis (PCA), and LASSO modeling. Multiplex ELISA-based assessment of sera from two independent cohorts (VA, ACR) of RA patients revealed a number of non-overlapping biomarkers distinguishing RA-ILD from RA-no ILD in adjusted regression models. Parallel analysis of sera from IPF patients also yielded a discriminatory panel of protein markers in age/sex/smoking adjusted models that showed differential overlap with profiles linked to RA-ILD in the VA versus ACR cohorts. PCA revealed several distinct functional groups of RA-ILD-associated markers that, in the VA cohort, encompassed pro-inflammatory cytokines/chemokines as well as two different subsets of MMPs. Finally, LASSO regression modeling in the ACR and VA cohorts revealed distinct biomarker combinations capable of discriminating RA-ILD from RA-no ILD. Comparative serum protein biomarker profiling represents a viable method for distinguishing RA-ILD from RA-no ILD and identifying population-specific mediators shared with IPF.